Labetalol Hydrochloride Injection, Solution
Product Images NDC 55154-4747

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 55154-4747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Labetalol 01)

FDA Label Image

Structural Formula Labetalol HCl (Labetalol 02)

Structural Formula Labetalol HCl (Labetalol 02)
Chemical structure diagram of Labetalol Hydrochloride showing molecular connectivity including aromatic rings and functional groups with a hydrochloride component.*
FDA Label Image

Hospira Logo (Labetalol 03)

FDA Label Image

20mg/4ml Bag Label (7ba44762 B760 4a8f Adce 65bf78cc5d98 00)

20mg/4ml Bag Label (7ba44762 B760 4a8f Adce 65bf78cc5d98 00)
Labetalol Hydrochloride Injection USP 20 mg/4 mL (5 mg/mL) in a sterile cartridge unit with Luer lock, labeled as 5 x 4 mL Carpuject cartridges. The label states it is for intravenous use only and distributed by Cardinal Health 107, LLC and Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.